| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 46.578 | 154.075 | 173.586 | 173.976 | 176.433 | 95.127 |
| Total Income - EUR | - | - | - | - | 46.840 | 154.075 | 173.588 | 173.976 | 176.433 | 95.127 |
| Total Expenses - EUR | - | - | - | - | 44.152 | 134.218 | 160.694 | 205.153 | 171.277 | 206.803 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.688 | 19.857 | 12.894 | -31.177 | 5.156 | -111.676 |
| Net Profit/Loss - EUR | - | - | - | - | 1.283 | 17.039 | 9.897 | -32.959 | 3.389 | -114.096 |
| Employees | - | - | - | - | 0 | 1 | 1 | 1 | 3 | 1 |
Check the financial reports for the company - Farmacos Bogdan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 945 | 927 | 394 | 313 | 231 | 0 |
| Current Assets | - | - | - | - | 40.229 | 50.759 | 96.302 | 80.973 | 150.666 | 21.433 |
| Inventories | - | - | - | - | 39.348 | 29.046 | 33.447 | 64.668 | 139.137 | 14.039 |
| Receivables | - | - | - | - | 3 | 2.111 | 402 | 1.083 | 15.459 | 2.643 |
| Cash | - | - | - | - | 879 | 19.603 | 62.453 | 15.222 | -3.930 | 4.751 |
| Shareholders Funds | - | - | - | - | 1.325 | 18.339 | 10.040 | -32.590 | -29.103 | -143.266 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 41.041 | 34.516 | 87.799 | 113.876 | 180.000 | 164.699 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Farmacos Bogdan S.r.l.